A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study Meeting Abstract
| Authors: | Paik, P.; Cortot, A.; Felip, E.; Sakai, H.; Mazieres, J.; Horn, L.; Griesinger, F.; Bruns, R.; Scheele, J.; Straub, J.; Veillon, R. |
| Abstract Title: | A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study |
| Meeting Title: | 2018 European Lung Cancer Congress (ELCC) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Apr 10-13 |
| Meeting Location: | Geneva, Switzerland |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-04-01 |
| Start Page: | mdz063.080 |
| Language: | English |
| ACCESSION: | WOS:000478089000180 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz063.080 |
| Notes: | Meeting Abstract: 182TiP -- Appears on page ii66 of the abstract book -- Source: Wos |
